Dec. 12, 2012
The US Food and Drug Administration (FDA), in conjunction with Ranbaxy Pharmaceuticals, Inc., recently issued a voluntary recall on the drug, Atorvastatin, due to a potential health risk. According to an FDA press release, contamination within the packaging of the drug could lead to serious side effects.
On Nov. 9, the company announced that certain lots of 10mg, 20mg, and 40 mg doses of Atorvastatin in 90 and 500-count bottles may contain glass particles the size of a grain of sand.
The drug is used to lower cholesterol levels. While no adverse events have been reported, anyone that has experienced an Indianapolis Drug Injury is urged to contact the FDA immediately. While officials have stated the risk of injury from the contamination is extremely low, any adverse events should pass quickly and harmlessly.
Anyone in possession of medication from the affected lots is being instructed to continue taking the medication as prescribed until a doctor or pharmacist can be reached to arrange for a replacement of the contaminated drugs. There is no shortage of the drug at this time.
The Indianapolis Personal Injury Lawyers with Stewart & Stewart Attorneys say that taking any medication can come with serious risks and the firm’s team of attorneys is here to help you if you have been harmed by a medication prescribed to you by a doctor.